Malignant peritoneal mesothelioma is a rare disease, with approximately 800 new patients per year in the United States. Its natural history is defined by progression restricted to the peritoneal space ...

Please provide your email address to receive an email when new articles are posted on . Atezolizumab plus bevacizumab appeared well-tolerated and resulted in a 40% objective response rate among ...

A phase II study found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective response rate in patients with advanced malignant peritoneal mesothelioma, a ...

Please provide your email address to receive an email when new articles are posted on . “In clinic, we have seen some people experience durable clinical benefit from pembrolizumab, so I was not ...

A phase II study led by researchers from The University of Texas MD Anderson Cancer Center found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective ...

The diagnosis of a malignant mesothelioma in the greater omentum is unexpected, since metastases are the most common tumors of the greater omentum, while primary tumors in this location are very rare.

Malignant mesothelioma is a rare type of cancer that grows in the thin layer of tissue that covers the heart, lungs and other internal organs. This membrane, called mesothelium, protects organs by ...

PLYMOUTH MEETING, PA [March 9, 2022] — The National Comprehensive Cancer Network ® (NCCN ®)—an alliance of leading cancer centers—today announced the publication of new NCCN Clinical Practice ...

An electrician diagnosed with a rare asbestos-related cancer has been awarded a $2.26 million payout for exposure to toxic ...

Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. If you have the appropriate software installed, you can download article citation data to ...